Loading...
XSWX
VBSN
Market cap383mUSD
Jul 09, Last price  
130.00CHF
1D
-1.52%
1Q
-7.14%
Jan 2017
-35.87%
IPO
52.85%
Name

IVF Hartmann Holding AG

Chart & Performance

D1W1MN
XSWX:VBSN chart
P/E
16.92
P/S
1.91
EPS
7.68
Div Yield, %
4.77%
Shrs. gr., 5y
0.21%
Rev. gr., 5y
-1.34%
Revenues
162m
+1.81%
108,354,000106,717,000103,956,000113,673,000117,608,000118,594,000125,998,000125,434,000132,939,000132,288,000134,693,000133,450,000134,049,000137,998,000172,919,000144,067,000150,649,000147,953,000158,792,000161,668,000
Net income
18m
-9.89%
4,423,0004,754,0006,188,00010,359,00012,380,00013,166,00014,815,00015,346,00015,777,00016,091,00016,447,00016,010,00014,070,00012,169,00017,825,0006,209,00011,225,00015,148,00020,302,00018,294,000
CFO
21m
+5.19%
10,397,0004,993,00012,261,00010,321,00016,317,00015,982,00015,815,00017,775,00016,771,00020,642,00018,488,00016,642,00013,444,00018,020,00030,888,000-2,511,00017,719,00033,825,00020,398,00021,456,000
Dividend
Apr 17, 20256.2 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Headquartered in Neuhausen am Rheinfall, Switzerland, IVF Hartmann Holding AG is a global supplier of medical consumer products. Its extensive portfolio encompasses disposable items for surgical use, including instruments, blankets, clothing, and gloves, alongside solutions for disinfection, hygiene, wound management (featuring hydrotherapy services), incontinence care, and first aid. The company also offers a variety of educational courses. IVF Hartmann caters to a broad spectrum of clients, such as private medical practitioners, outpatient facilities, hospitals, clinics, pharmacies, drugstores, nursing homes, medical and food retail outlets, and various industrial sectors. Established in 1874, the company was initially known as IVF before adopting its current name, IVF Hartmann Holding AG, in 1993. It operates as a subsidiary of Paul Hartmann Finance B.V.
IPO date
Jul 16, 2012
Employees
293
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT